Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Los Angeles, USA
10924 Le Conte Avenue
Los Angeles, CA, 90024
USA

People

Director

Funding

TOTAL $35.3M
FUNDING TOTAL $35.3M
Series A, 3/2011
Riverbank Capital Securities
$15M
Seed, 12/2012
$250k
Series A, 5/2013
Alta Partners
$20M

Tags

Kite Pharma

Kite Pharma is a privately held development stage biotechnology company engaged in the design and development of pioneering immune-based targeted therapies to treat different cancer indications. Kite has a portfolio of proprietary product candidates designed to stimulate the patient’s own immune system to fight tumor cells. These potential therapies could provide novel strategies for the treatment and management of a wide range of tumor types.

Recent Milestones

Videos

Screenshots

Kite Pharma screenshot
Above: Kite Pharma
Uploaded: 3/10/11

Sources

  1. Kite Pharma Raises $15 Million in Initial Round of Financing and Appoints David Bonderman to Board of Directors (finance.yahoo.com) [edit]
  2. SEC (sec.gov) [edit]
  3. UPDATED: Billionaires back Kite Pharma in $20M raise for cancer immunotherapies (fiercebiotech.com) [edit]
Edit This Page
Last Edited 12/17/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy